Science Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2023-09-06 喵了个咪5371 来自山东省

under evaluation快一个月了，是编辑忘了吗

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2023-06-16 默默0606 来自北京

请问一下投这个杂志后是必须所以作者都要同意认证吗？

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2015-07-27 lao6

IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？

608 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2023-02-23 ms2000000439007736 来自山东省

想问下，from review后会拒稿嘛？

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2021-01-26 ms4000001898750078

有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂

433 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2020-06-01 12214f1fm92(暂无昵称)

审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0
偏重的研究方向：肿瘤免疫;T 细胞治疗
经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！

517 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2020-01-23 dama20081110_27249103

To review, 是送审了吗

274 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2022-06-27 ms9000001863860369

中一篇这个，能中国自然青年基金不？

239 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2022-05-25 aming1982

审稿速度:2.0 | 投稿命中率:5.0
经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄

246 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156339, encodeId=ed38215633989, content=under evaluation快一个月了，是编辑忘了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Wed Sep 06 09:43:05 CST 2023, time=2023-09-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2143145, encodeId=294421431452e, content=请问一下投这个杂志后是必须所以作者都要同意认证吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Fri Jun 16 14:55:24 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=513935, encodeId=8ba3513935aa, content=IF15不算低，但很高吗？讽刺我很有意思？我们实验室不算很牛，但这个水平以上的文章还是有一些的。我们的文章是Science和Nature下来的，怎么就不能试试这个杂志了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=608, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Mon Jul 27 15:38:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116194, encodeId=cc502116194cc, content=想问下，from review后会拒稿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5008314535, createdName=ms2000000439007736, createdTime=Thu Feb 23 23:22:19 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=919994, encodeId=f00f91999487, content=有没有小伙伴了解修回到接收的时间呀。小修revise之后，经历了两轮to review 到 under evaluation。本来一审只安排了两个reviewer，意见都很积极，以为会比较顺利，然而现在卡在under evaluation又不动了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b5455877, createdName=ms4000001898750078, createdTime=Tue Jan 26 13:38:16 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600992, encodeId=e2a86009921b, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:2100.0 偏重的研究方向：肿瘤免疫;T 细胞治疗 经验分享：去年8月份开始投稿，editor比较nice，喜欢这个课题，给了外审，审稿6周左右，10月初大修回来，3个reviewer给的意见都很中肯，因为需要补充实验较多，editor给了resubmit的机会，补实验4个月后，20年2月初，投回去，大修结束，3个reviewer对修回结果满意，3月初意见回来，至此进入小修阶段，没有再补充实验，后面小修2次，第一次用了6周，5月初回来，editor非常负责，对文章表述要求很严格严谨，进行了部分润色以及与作者沟通各种细节，第二次用了2周，进行二次确认细节，5月底接收，总的来说，需要比较新颖的idea以及严谨的数据支持，临床数据支持。估计到见刊，大约需要1年时间！另外，版面费相对较低，一篇NC或者SA的版面费可以发2篇STM了，性价比很高哦，写下来，希望能给各位参考！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5b32304995, createdName=12214f1fm92(暂无昵称), createdTime=Mon Jun 01 10:39:24 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583775, encodeId=d982583e7582, content=To review, 是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ae45268979, createdName=dama20081110_27249103, createdTime=Thu Jan 23 08:03:00 CST 2020, time=2020-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229006, encodeId=311d122900697, content=中一篇这个，能中国自然青年基金不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=edca5545927, createdName=ms9000001863860369, createdTime=Mon Jun 27 19:24:57 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222206, encodeId=20421222206a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：杂志要求很高，编辑非常细心严谨，投稿修稿周期很长，课题组论文先后修了五轮一年多时间，大家得有心理准备，祝好运😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/08/a88c79e15067a29ecad74a7b0022bc9e.jpg, createdBy=b3be1642933, createdName=aming1982, createdTime=Wed May 25 00:21:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573141, encodeId=b13e5e314190, content=想问下to advisor 这个状态大概持续多久呢？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/30/c1db4bfb0502993b16e5653d8dfd01a1.jpg, createdBy=0e235116205, createdName=水地比, createdTime=Sun Jun 30 00:00:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

2019-06-30 水地比

想问下to advisor 这个状态大概持续多久呢？谢谢

469 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务